US 11976122
Anti-IL13Rα2 antibodies
granted A61KA61K47/6801A61P
Quick answer
US patent 11976122 (Anti-IL13Rα2 antibodies) held by ADC THERAPEUTICS SA expires Mon May 02 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- ADC THERAPEUTICS SA
- Grant date
- Tue May 07 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 02 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61K, A61K47/6801, A61P, A61P35/00